{"id":82574,"date":"2025-11-11T14:23:29","date_gmt":"2025-11-11T14:23:29","guid":{"rendered":"https:\/\/www.cofb.org\/?p=82574"},"modified":"2025-11-17T14:52:13","modified_gmt":"2025-11-17T14:52:13","slug":"migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/","title":{"rendered":"Migranya: Gesti\u00f3, tractament i abordatge integral, en una nova actualitzaci\u00f3 formativa al COFB."},"content":{"rendered":"\n

El Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong> va organitzar el passat 23 d\u2019octubre la formaci\u00f3 \u201cActualitzaci\u00f3 en migranya<\/strong>\u201d, amb la col\u00b7laboraci\u00f3 de Pfizer <\/a>i la Societat Catalana de Farm\u00e0cia Cl\u00ednica<\/a>. La sessi\u00f3 va ser impartida per Laura Dorado<\/strong>, neur\u00f2loga, responsable de la Unitat de Cefalees de l’Hospital Universitari Germans Trias i Pujol i Coordinadora del grup d’estudi en cefalees de la Societat Catalana de Neurologia; Gl\u00f2ria Cardona<\/strong>, farmac\u00e8utica adjunta responsable de l’\u00e0rea de pacients externs del Servei de Farm\u00e0cia de l’Hospital Universitari Germans Trias i Pujol; Paula Arellano,<\/strong> farmac\u00e8utica d’Atenci\u00f3 Prim\u00e0ria de la ger\u00e8ncia Barcelon\u00e8s Nord i Maresme de l\u2019Institut Catal\u00e0 de la Salut; i Eloi Merencio<\/strong>, farmac\u00e8utic comunitari en Farm\u00e0cia Naudin, professor associat del Grau de Farm\u00e0cia de la Universitat Ramon Llull, i vocal de Farm\u00e0cia Comunit\u00e0ria de la Societat Catalana de Farm\u00e0cia Cl\u00ednica i tresorer de SEFAC Catalunya. Cristina Morales<\/strong>, vocal d’Atenci\u00f3 Prim\u00e0ria del COFB, i Merc\u00e8 Barau<\/strong>, vocal d’Oficina de Farm\u00e0cia del COFB, van moderar la sessi\u00f3.<\/p>\n\n\n\n

Els objectius de la formaci\u00f3 van ser con\u00e8ixer les caracter\u00edstiques de la migranya<\/strong> i el seu impacte, actualitzar la gesti\u00f3 i el tractament <\/strong>de la migranya, revisar aspectes d’atenci\u00f3 farmac\u00e8utica <\/strong>relacionats amb la dispensaci\u00f3 i el seguiment i, finalment, exposar l’abordatge multidisciplinari<\/strong> del pacient amb migranya.<\/p>\n\n\n\n

\"Merc\u00e8<\/a>
Merc\u00e8 Barau, vocal d’Oficina de Farm\u00e0cia del COFB, i Cristina Morales, vocal d’Atenci\u00f3 Prim\u00e0ria del COFB, van moderar la sessi\u00f3.<\/figcaption><\/figure>\n\n\n\n

Adre\u00e7ada a farmac\u00e8utics\/es d\u2019atenci\u00f3 prim\u00e0ria i comunitaris, la vocal d\u2019Atenci\u00f3 Prim\u00e0ria del COFB, Cristina Morales<\/strong>, va recordar que aquesta sessi\u00f3 \u201cbusca seguir el fil que va posar en marxa el col\u00b7legi en els \u00faltims anys, donant visibilitat a l\u2019abordatge integral <\/strong>de cadascun dels problemes de salut<\/strong> que des d\u2019una perspectiva cl\u00ednica i assistencial <\/strong>intervenen en el dia a dia del farmac\u00e8utic\u201d.<\/p>\n\n\n\n

Merc\u00e8 Barau<\/strong>, vocal d’Oficina de Farm\u00e0cia del COFB, va afirmar que aquesta confer\u00e8ncia \u201cservir\u00e0 per veure la import\u00e0ncia que s\u2019ha de donar a aquest mal de cap<\/strong>, qu\u00e8 haig de preguntar al professional i quins medicaments s\u2019han de con\u00e8ixer des de la farm\u00e0cia<\/strong>\u201d.<\/p>\n\n\n\n

El nexe entre migranya i gen\u00e8tica<\/h2>\n\n\n\n

Durant la seva pon\u00e8ncia, Laura Dorado<\/strong> va recordar que la migranya \u201c\u00e9s una malaltia molt prevalent <\/strong>que arriba a afectar entre el 12% i 13% de la poblaci\u00f3 mundial<\/strong>. Pel que fa a Espanya, hi ha 5 milions de pacients amb migranya<\/strong> i una de cada cinc dones ho pateix. Avui dia, encara \u00e9s el motiu neurol\u00f2gic de consulta m\u00e9s freq\u00fcent<\/strong> dins l\u2019atenci\u00f3 prim\u00e0ria\u201d.<\/p>\n\n\n\n

\"La<\/a>
La migranya segueix sent, tal i com va confirmar Laura Dorado, el motiu neurol\u00f2gic de consulta m\u00e9s freq\u00fcent dins l’atenci\u00f3 prim\u00e0ria.<\/figcaption><\/figure>\n\n\n\n

Un cop ens endinsem dins la fisiopatologia, Dorado va explicar que aquesta malaltia va unida a \u201cuna degradaci\u00f3 familiar molt important<\/strong>. El fet que passi aix\u00f2 ha provocat que hi hagi un inter\u00e8s per con\u00e8ixer el factor gen\u00e8tic subjacent<\/strong>, i diversos estudis gen\u00e8tics d\u2019alt rendiment<\/strong> han identificat 123 loci de risc per migranya<\/strong>, modificant funcions vasculars i neuronals\u201d.<\/p>\n\n\n\n

Tractaments per la migranya: Els f\u00e0rmacs anti-CGRP<\/h2>\n\n\n\n

Pel que fa a les opcions terap\u00e8utiques<\/strong> per a la prevenci\u00f3 <\/strong>i el tractament de la migranya<\/strong>, Gl\u00f2ria Cardona<\/strong> va fer \u00e8mfasi en la necessitat de \u201creduir les caracter\u00edstiques globals de la malaltia<\/strong>, millorar la resposta al tractament agut, reduir la discapacitat i evitar la cefalea <\/strong>per ab\u00fas de medicaci\u00f3 simptom\u00e0tica<\/strong>\u201d.<\/p>\n\n\n\n

\"Gloria<\/a>
Gl\u00f2ria Cardona, en un moment de la seva presentaci\u00f3.<\/figcaption><\/figure>\n\n\n\n

Despr\u00e9s del sorgiment dels f\u00e0rmacs anti-CGRP,<\/strong> \u201cs\u2019ha aconseguit obtenir el primer tractament preventiu per bloquejar selectivament el CGRP<\/strong>. Abans, s\u2019usaven eines terap\u00e8utiques heretades d’altres branques del coneixement m\u00e8dic, com s\u00f3n els antihipertensius<\/strong>, antidepressius <\/strong>i neuromoduladors<\/strong>, entre d’altres\u201d. Per concloure, l\u2019especialista va remarcar que \u201cel tractament preventiu amb anti-CGRP en pacients amb migranya \u00e9s efectiu i aconsegueix una reducci\u00f3 significativa<\/strong> i sostinguda dels dies de migranya al mes<\/strong>\u201d.<\/p>\n\n\n\n

Les crisis agudes de migranya i els seus efectes<\/h2>\n\n\n\n

L\u2019impacte <\/strong>que tenen les crisis de migranya en un pacient <\/strong>va ser descrit per Paula Arellano<\/strong>: \u201cEn l\u2019\u00e0mbit personal <\/strong>\u00e9s una malaltia que impedeix continuar amb la vida quotidiana. En l\u2019\u00e0mbit social<\/strong>, el pacient deixa de quedar amb amics per por a un nou atac. Finalment, a escala laboral <\/strong>un percentatge dels pacients amb migranya s\u00f3n actius laboralment parlant, i per aix\u00f2 hi ha molt absentisme<\/strong> i es generen moltes baixes<\/strong>\u201d. En aquest sentit, \u201cun 25% dels pacients arriba a perdre la feina i un 28% no pot ascendir\u201d.<\/p>\n\n\n\n

\"Paula<\/a>
Paula Arellano va recordar que, a escala laboral, un 25% dels pacients amb migranya perden la feina i un 28% no pot ascendir.<\/figcaption><\/figure>\n\n\n\n

Els punts clau en l\u2019elecci\u00f3 del tractament simptom\u00e0tic s\u00f3n \u201cindividualitzar el tractament<\/strong> per cada pacient, segons el tipus de crisi, intensitat, comorbiditats i prefer\u00e8ncies; evitar l\u2019ab\u00fas de medicaci\u00f3<\/strong>, evitar la via oral si les crisis s\u00f3n amb v\u00f2mits i prendre\u2019s el tractament de manera preco\u00e7<\/strong>\u201d, va puntualitzar Arellano.<\/p>\n\n\n\n

Mesures de prevenci\u00f3 enfront de les migranyes<\/h2>\n\n\n\n

Finalment, el farmac\u00e8utic comunitari Eloi Merencio<\/strong> va centrar la seva pon\u00e8ncia a descriure les mesures de prevenci\u00f3 <\/strong>que s\u2019han de posar en marxa quan un pacient pateix migranya: \u201c\u00c9s important un horari de son constant<\/strong>, t\u00e8cniques de relaxaci\u00f3<\/strong>, exercici aer\u00f2bic regular <\/strong>i consum <\/strong>moderat i estabilitzat de cafe\u00efna i alcohol<\/strong>, entre d\u2019altres\u201d.<\/p>\n\n\n\n

\"Les<\/a>
Les mesures de prevenci\u00f3 que s’han d’iniciar quan un pacient pateix migranya van ser descrites per Eloi Merencio.<\/figcaption><\/figure>\n\n\n\n

Per altra banda, si el pacient necessita un tractament agut de la crisi <\/strong>de la migranya<\/strong>, Merencio va remarcar la necessitat de \u201cdur a terme descans sensorial<\/strong>, termoter\u00e0pia local<\/strong>, hidrataci\u00f3 i ter\u00e0pies f\u00edsiques <\/strong>per actuar enfront del mal que genera la migranya\u201d.<\/p>\n\n\n\n

<\/p>\n\n\n\n

\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n

Amb la col\u00b7laboraci\u00f3 de:<\/strong><\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n

<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

El Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar el passat 23 d\u2019octubre la formaci\u00f3 \u201cActualitzaci\u00f3 en migranya\u201d, amb la col\u00b7laboraci\u00f3 de Pfizer i la Societat Catalana de Farm\u00e0cia Cl\u00ednica. La sessi\u00f3 va ser impartida per Laura Dorado, neur\u00f2loga, responsable de la Unitat de Cefalees de l’Hospital Universitari Germans Trias […]<\/p>\n","protected":false},"author":10,"featured_media":82867,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[18,19,405,53,70,335,230,264],"class_list":["post-82574","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-farmac","tag-farmaceutics","tag-formacio","tag-medicacio","tag-migranya","tag-prevencio"],"yoast_head":"\nMigranya: Gesti\u00f3, tractament i abordatge integral, en una nova actualitzaci\u00f3 formativa al COFB. - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El COFB acull la jornada "Actualitzaci\u00f3 en migranya" per analitzar la seva, tractament i abordatge integral\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/ca\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Migranya: Gesti\u00f3, tractament i abordatge integral, en una nova actualitzaci\u00f3 formativa al COFB. - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El COFB acull la jornada "Actualitzaci\u00f3 en migranya" per analitzar la seva, tractament i abordatge integral\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/ca\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-11T14:23:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-17T14:52:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Xavier Magraner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Xavier Magraner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/\"},\"author\":{\"name\":\"Xavier Magraner\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\"},\"headline\":\"Migranya: Gesti\u00f3, tractament i abordatge integral, en una nova actualitzaci\u00f3 formativa al COFB.\",\"datePublished\":\"2025-11-11T14:23:29+00:00\",\"dateModified\":\"2025-11-17T14:52:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/\"},\"wordCount\":1029,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-scaled.jpg\",\"keywords\":[\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"f\u00e0rmac\",\"farmac\u00e8utics\",\"Formaci\u00f3\",\"medicaci\u00f3\",\"migranya\",\"prevenci\u00f3\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/\",\"url\":\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/\",\"name\":\"Migranya: Gesti\u00f3, tractament i abordatge integral, en una nova actualitzaci\u00f3 formativa al COFB. - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-scaled.jpg\",\"datePublished\":\"2025-11-11T14:23:29+00:00\",\"dateModified\":\"2025-11-17T14:52:13+00:00\",\"description\":\"El COFB acull la jornada \\\"Actualitzaci\u00f3 en migranya\\\" per analitzar la seva, tractament i abordatge integral\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Migranya: Gesti\u00f3, tractament i abordatge integral, en una nova actualitzaci\u00f3 formativa al COFB.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4\",\"name\":\"Xavier Magraner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g\",\"caption\":\"Xavier Magraner\"},\"url\":\"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Migranya: Gesti\u00f3, tractament i abordatge integral, en una nova actualitzaci\u00f3 formativa al COFB. - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El COFB acull la jornada \"Actualitzaci\u00f3 en migranya\" per analitzar la seva, tractament i abordatge integral","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/ca\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/","og_locale":"ca_ES","og_type":"article","og_title":"Migranya: Gesti\u00f3, tractament i abordatge integral, en una nova actualitzaci\u00f3 formativa al COFB. - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El COFB acull la jornada \"Actualitzaci\u00f3 en migranya\" per analitzar la seva, tractament i abordatge integral","og_url":"https:\/\/www.cofb.org\/ca\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2025-11-11T14:23:29+00:00","article_modified_time":"2025-11-17T14:52:13+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-scaled.jpg","type":"image\/jpeg"}],"author":"Xavier Magraner","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"Xavier Magraner","Temps estimat de lectura":"7 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/"},"author":{"name":"Xavier Magraner","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4"},"headline":"Migranya: Gesti\u00f3, tractament i abordatge integral, en una nova actualitzaci\u00f3 formativa al COFB.","datePublished":"2025-11-11T14:23:29+00:00","dateModified":"2025-11-17T14:52:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/"},"wordCount":1029,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-scaled.jpg","keywords":["COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","f\u00e0rmac","farmac\u00e8utics","Formaci\u00f3","medicaci\u00f3","migranya","prevenci\u00f3"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/","url":"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/","name":"Migranya: Gesti\u00f3, tractament i abordatge integral, en una nova actualitzaci\u00f3 formativa al COFB. - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-scaled.jpg","datePublished":"2025-11-11T14:23:29+00:00","dateModified":"2025-11-17T14:52:13+00:00","description":"El COFB acull la jornada \"Actualitzaci\u00f3 en migranya\" per analitzar la seva, tractament i abordatge integral","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2025\/11\/11\/migranya-gestio-tractament-i-abordatge-integral-en-una-nova-actualitzacio-formativa-al-cofb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Migranya: Gesti\u00f3, tractament i abordatge integral, en una nova actualitzaci\u00f3 formativa al COFB."}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/e46d741cfb92c985a083d163d8270ae4","name":"Xavier Magraner","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa0d1d4df59f71f88eebd5796c5388ff41c58d83c5301eb6e1d65646a289c37d?s=96&d=mm&r=g","caption":"Xavier Magraner"},"url":"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2025\/11\/COFB_MIGRANYA_17112025_DESTACADA-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Xavier Magraner","author_link":"https:\/\/www.cofb.org\/ca\/author\/xmagraner\/"},"uagb_comment_info":0,"uagb_excerpt":"El Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar el passat 23 d\u2019octubre la formaci\u00f3 \u201cActualitzaci\u00f3 en migranya\u201d, amb la col\u00b7laboraci\u00f3 de Pfizer i la Societat Catalana de Farm\u00e0cia Cl\u00ednica. La sessi\u00f3 va ser impartida per Laura Dorado, neur\u00f2loga, responsable de la Unitat de Cefalees de l’Hospital Universitari Germans Trias […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/82574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=82574"}],"version-history":[{"count":19,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/82574\/revisions"}],"predecessor-version":[{"id":82874,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/82574\/revisions\/82874"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/82867"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=82574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=82574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=82574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}